New implementations for MD UDI

A new deadline is getting close in the world of medical devices (MDs) and in vitro diagnostics (IVDs).
As of 26 May 2025, the UDI vectors shall be reported in the label or in the MD itself and in all levels of packaging for the MDs in class I and for reusable MDs in class IIa and IIb.
As of the same date, the UDI vector shall also appear in the label or in the IVD itself and in all levels of packaging for the IVDs in class B and C.
The following table summarises the deadlines for the application of the UDI vector:
| MDR-certified device Regulation EU 2017/745 | Implantable and class III devices | Class IIa and class IIb devices | Class I devices |
| Application of the UDI vector on the device labels Article 123(3)(f), Article 27(4) | 26 May 2021 | 26 May 2023 | 26 May 2025 |
| Direct marking of reusable devices Article 123(3)(g), Article 27(4) | 26 May 2023 | 26 May 2025 | 26 May 2027 |
| IVDR-certified device Regulation EU 2017/746 | Class D devices | Class C and class B devices | Class A devices |
| Application of the UDI vector on the device labels Article 113(3)(e), Article 24(4) | 26 May 2023 | 26 May 2025 | 26 May 2027 |
But what is the UDI vector and how can it be depicted?
The UDI vector is the graphic representation of the UDI code.
It can be represented in two formats:
- The HRI (Human Readable Interpretation) format: an alphanumeric string including all required information, according to the adopted standard, to indicate the UDI code;
- The AIDC (Automatic Identification and Data Capture): a graphic representation of the information regarding the UDI code allowing its automatic reading. Different formats are provided for and accepted depending on the body chosen for its release. These include the ID/linear barcode, 2D barcode and RFID.
Do the same rules apply for all MDs and IVDs?
Of course not, it would be too easy.
Regulations EU 2017/745 and 2017/746, in the respective part C of Annex VI, both specify some cases for which a waiver is admitted on how to apply the UDI code.
For easy reading, henceforth we will use the term “device” to indicate both MDs and IVDs.
Space limits
In case of relevant limits preventing the use of both AIDC and HRI formats in the label, only the AIDC format can be reported.
Moreover, in case of relevant space limits in the unit packaging, the UDI vector can be reported in the sole outer packaging.
Single-use devices packaged and labelled individually
For single-use devices in class A and B and in class I and IIa that are packaged and labelled individually it is not needed that the UDI vector is reported on the pack, it can be applied on the outer packaging, for instance on the carton containing more individually packaged devices. However, in the case where healthcare professionals have no access to the outer packaging of a device, such as in home care, then the UDI vector is reported in the package.
Reusable devices
These must include the UDI vector on the device itself, so by means of a direct marking.
This requirement does not apply in the following cases:
- Any kind of direct marking that would interfere with the safety and performance of the device;
- The device cannot be marked directly as it is not possible from a technological point of view.
With their 40 years of experience, Di Renzo Regulatory Affairs can assist you in the implementation of the Quality System for Medical Devices and In Vitro Diagnostics, in compliance with the requirements established by the regulation, providing their customers with full assistance.
Di Renzo Regulatory Affairs has a highly qualified staff dedicated to the quality management services and can assist interested companies in the following activities:
- Consultancy for the implementation and maintenance of the Quality Management System (QMS) according to ISO 13485
- Gap analysis for the verification of the Quality Management System
- Drafting of the Quality Manual
- Drafting of Standard Operating Procedures (SOPs)
- Set-up of the data recording system
- Assumption of the role of Quality Assurance for ISO 13485 systems
- Audits of the Quality Management Systems of manufacturers and/or distributors
- Audits before and after the inspection by Notified Bodies and Competent Authorities at manufacturers and manufacturing sites of medical devices
- Audits at manufacturers of medical devices to assess the level of compliance with ISO 13485
- Assistance in the management of non-conformities and in corrective and preventive actions (CAPAs)
- Participation to meetings to review the executive management and/or support in the drafting the relevant minutes (Management Review)
- In-house training on the QMS and on the general principles of specific ISOs
- Advise on the implementation and maintenance of the post-marketing surveillance system
Previous Post
Next Post